Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30014909HIVENSG00000133703.14protein_codingKRASYesNo3845L7RSL8
P01116
TVIS30032316HIVENSG00000133703.14protein_codingKRASYesNo3845L7RSL8
P01116
TVIS30032317HIVENSG00000133703.14protein_codingKRASYesNo3845L7RSL8
P01116
TVIS30032318HIVENSG00000133703.14protein_codingKRASYesNo3845L7RSL8
P01116
TVIS30032319HIVENSG00000133703.14protein_codingKRASYesNo3845L7RSL8
P01116
TVIS20043514HPVENSG00000133703.14protein_codingKRASYesNo3845L7RSL8
P01116
TVIS44010711HTLV-1ENSG00000133703.14protein_codingKRASYesNo3845L7RSL8
P01116
TCGA Plot Options
Drug Information
GeneKRAS
DrugBank IDDB15568
Drug NameAdagrasib
Target IDBE0004071
UniProt IDP01116
Regulation Typeinhibitor
PubMed IDs31658955
CitationsChristensen JG, Hallin J, Engstrom LD, Hargis L, Calinisan A, Aranda R, Briere DM, Sudhakar N, Bowcut V, Baer BR, Ballard JA, Burkard MR, Fell JB, Fischer JP, Vigers GP, Xue JY, Gatto S, Fernandez-Banet J, Pavlicek A, Velastegui K, Chao RC, Barton J, Pierobon M, Baldelli E, Patricoin EF, Cassidy DP, Marx MA, Rybkin II, Johnson ML, Ou SI, Lito P, Papadopoulos KP, Janne PA, Olson P: The KRASG12C Inhibitor, MRTX849, Provides Insight Toward Therapeutic Susceptibility of KRAS Mutant Cancers in Mouse Models and Patients. Cancer Discov. 2019 Oct 28. pii: 2159-8290.CD-19-1167. doi: 10.1158/2159-8290.CD-19-1167.
GroupsApproved; Investigational
Direct Classification
SMILES[H][C@@]1(COC2=NC3=C(CCN(C3)C3=CC=CC4=C3C(Cl)=CC=C4)C(=N2)N2CCN(C(=O)C(F)=C)[C@@]([H])(CC#N)C2)CCCN1C
Pathways
PharmGKB
ChEMBLCHEMBL4594350